Wednesday, April 2, 2025
4/2/2025
Targeting heat shock protein 72 to improve renal function after transplantation - PROJECT SUMMARY ABSTRACT Long-term allograft function tends to be poor for people who receive kidneys from deceased donors, which comprise 70% of total transplants. A key contributor to these poor outcomes is cold storage (CS) of the organs, which induces injury during preservation. Accordingly, there is an urgent need to understand the mechanisms by which CS activates molecular pathways that induce renal damage in the recipient. Our long-term goal is to identify these CS-related pathways and apply targeted therapies during CS to improve outcomes and decrease transplant-associated mortality. One of the important molecular determinants of CS-induced kidney injury is abnormal protein homeostasis. During stress, heat-shock proteins and the proteasome play a concerted role in maintaining protein homeostasis. Hsp72 is the major stress-inducible homologue of Hsc70, the cognate member of the heat-shock protein 70 family that exhibits housekeeping function in all nucleated cells and is necessary for cell survival. Importantly, Hsc70 and Hsp72 play critical roles by binding damaged proteins and recruiting the proteasome for targeted degradation, preventing the nonspecific aggregation of damaged proteins. In addition to its protective roles, Hsp72 is implicated in the pathogenesis of numerous human diseases by modulating the immune system and inflammation. Using a clinically relevant rat model of renal CS combined with transplantation, we showed that CS decreases proteasome function and impairs protein homeostasis in the transplants. How CS decreases proteasome function in the transplants is not known. We hypothesize that CS- mediated activation of HSF1 and p38MAPK mediate the upregulation of Hsp72 and phosphorylation of Rpt6, leading to proteasome dysfunction and injury after transplantation. We have preliminary data supporting this hypothesis. We have also established animal models of CS/transplantation, which mimic the clinical reality more effectively than simple CS/warm perfusion and will allow us to test our hypothesis through 3 specific aims. Aim 1: Define the mechanism of Hsp72 upregulation and its impact on proteasome dysfunction during renal CS and transplantation. Aim 2: Delineate the mechanism of Rpt6 phosphorylation/aggregation and its impact on proteasome dysfunction during renal CS and transplantation. Aim 3: Determine the therapeutic utility of the Hsp72 inhibitor HS-72 using both rat and human models of renal CS and transplantation. This project uses a clinically relevant rat kidney transplant model as well as ex vivo human kidney perfusion pump to test the effects of novel CS-based therapies (e.g., HS-72) on proteasome/renal function after transplantation. We expect to identify molecular mediators of proteasome dysfunction and renal injury following CS and transplantation. These findings would be readily translatable, such as by administering drugs targeting these pathways to the CS solution to improve transplant outcomes and reduce mortality for transplant patients with end-stage kidney disease.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).